Clinical trial
Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung…
NCT00004265 · University of Wisconsin, Madison, Other · Unknown status
Key facts
| NCT number | NCT00004265 |
|---|---|
| Title | Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer |
| Official title | Phase II Study of Weekly Paclitaxel as Second-Line Therapy in Patients With Non-Small Cell Lung Cancer |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Start date | Feb 1, 1999 |
| First posted | Jul 26, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: